DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Lee, Sang Yup | - |
dc.contributor.advisor | 이상엽 | - |
dc.contributor.author | Park, Yae Seul | - |
dc.date.accessioned | 2022-04-21T19:31:36Z | - |
dc.date.available | 2022-04-21T19:31:36Z | - |
dc.date.issued | 2021 | - |
dc.identifier.uri | http://library.kaist.ac.kr/search/detail/view.do?bibCtrlNo=949008&flag=dissertation | en_US |
dc.identifier.uri | http://hdl.handle.net/10203/295374 | - |
dc.description | 학위논문(석사) - 한국과학기술원 : 생명화학공학과, 2021.2,[iv, 67 p. :] | - |
dc.description.abstract | In the era of the 4th industrial revolution, bioindustry is getting huge attention and the biopharmaceutical market in particular is in the golden age. Biopharmaceuticals refer to pharmaceuticals made from proteins, genes, and cells derived from living organisms. Unlike synthetic pharmaceuticals, biopharmaceuticals have low intrinsic toxicity in the human body and are used as target treatments for various intractable and degenerative diseases. With increasing importance of research on bio-based production of biopharmaceuticals, heterologous expression through introduction of external biosynthetic pathways in microorganisms such as E. coli will be a good strategy for mass production of biopharmaceuticals. Indirubin is a red pigment contained in indigo leaves, and is an important biochemical substance that can be used as a treatment for cancer and leukemia. Lovastatin is a polyketide-based substance among natural products which can be used as a treatment for cancer and hyperlipidemia. Simvastatin is also a polyketide-based substance that is used as a treatment for cancer, cardiovascular disease, and hyperlipidemia. This study proposes an efficient method for the production of each substance by applying metabolic engineering strategies in E. coli. | - |
dc.language | eng | - |
dc.publisher | 한국과학기술원 | - |
dc.subject | Escherichia coli▼aMetabolic engineering▼aNatural products▼aBiopharmaceuticals▼aEnzyme engineering | - |
dc.subject | 대장균▼a대사공학▼a천연물▼a바이오제약품▼a효소공학 | - |
dc.title | Metabolic Engineering in Escherichia coli for the production of indirubin, lovastatin, and simvastatin | - |
dc.title.alternative | 대사공학을 이용한 대장균에서의 인디루빈, 로바스타틴, 심바스타틴 생산 연구 | - |
dc.type | Thesis(Master) | - |
dc.identifier.CNRN | 325007 | - |
dc.description.department | 한국과학기술원 :생명화학공학과, | - |
dc.contributor.alternativeauthor | 박예슬 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.